 |
 |
|
Home |
Current Issue |
Past Issues |
In the Clinic |
ACP Journal Club |
CME |
Collections |
Audio/Video |
Mobile |
Subscribe |
Tools |
Help |
ACP Online
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
7 November 2000 | Volume 133 Issue 9 | Pages 714-725
Background: Vasovagal syncope is the most common type of syncope and is one of the most difficult types to manage.
Purpose: This article reviews the status of mechanisms, diagnosis, and management of vasovagal syncope.
Data Sources: MEDLINE search for English-language and German-language articles on vasovagal syncope published up to June 1999.
Study Selection: Case reports and series, clinical trials, research investigations, and review articles from peer-reviewed journals.
Data Extraction: Findings were summarized and discussed individually. Summaries were made in table format. Statistical analysis of combined data was inappropriate because of differences among studies in patient selection, testing, and follow-up.
Data Synthesis: The population of patients with vasovagal syncope is highly heterogeneous. Triggers of vasovagal syncope are likely to be protean, and many potential central and peripheral triggers have been identified. The specific mechanisms underlying the interactions among decreased preload, sympathetic and parasympathetic modulation, vasodilation, and cardioinhibition remain unknown. Tilt-table testing is a widely used diagnostic tool. The test results should be interpreted in the context of patients' clinical presentations and with an understanding of the sensitivity and specificity of the test. Assessment of therapeutic outcomes has been difficult, primarily because of patient heterogeneity, the large number of pharmacologic agents available for therapy, and the sporadic nature of the syndrome complex.
Conclusions: Vasovagal syncope is a common clinical syndrome that has complex and variable mechanisms and is difficult to manage. Advancements are being made in laboratory investigations of its triggering mechanisms. Randomized, controlled trials of pharmacologic and nonpharmacologic interventions are needed. Mechanism-targeted therapeutic trials may improve clinical outcomes.
Author and Article Information
From the Mayo Clinic and the Mayo Foundation, Rochester, Minnesota.
Disclaimer: The Mayo Foundation does not endorse the products of Medtronic (Minneapolis, Minnesota).
Grant Support: By the National Institutes of Health (PPG NS3 2952) and by Medtronic.
Requests for Single Reprints: Win-Kuang Shen, MD, Mayo Clinic, 200 First Street SW, Rochester, MN 55905.
Current Author Addresses: Drs. Fenton, Hammill, Rea, Low, and Shen: Mayo Clinic, 200 First Street SW, Rochester, MN 55905. REVIEW
Series in Primary Care Internal Medicine
Vasovagal Syncope
This article has been cited by other articles:
|
|
 |
|
  T Pezawas, G Stix, J Kastner, B Schneider, M Wolzt, and H Schmidinger Implantable loop recorder in unexplained syncope: classification, mechanism, transient loss of consciousness and role of major depressive disorder in patients with and without structural heart disease Heart, April 1, 2008; 94(4): e17 - e17. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. T. P. Krediet, J. J. van Lieshout, L. W. J. Bogert, R. V. Immink, Y.-S. Kim, and W. Wieling Leg crossing improves orthostatic tolerance in healthy subjects: a placebo-controlled crossover study Am J Physiol Heart Circ Physiol, October 1, 2006; 291(4): H1768 - H1772. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J.-C. Deharo, C. Jego, A. Lanteaume, and P. Djiane An Implantable Loop Recorder Study of Highly Symptomatic Vasovagal Patients: The Heart Rhythm Observed During a Spontaneous Syncope Is Identical to the Recurrent Syncope But Not Correlated With the Head-Up Tilt Test or Adenosine Triphosphate Test J. Am. Coll. Cardiol., February 7, 2006; 47(3): 587 - 593. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. D. Binder, M. A. Fifer, M. E. King, and J. R. Stone Case 26-2005 - A 48-Year-Old Man with Sudden Loss of Consciousness while Jogging N. Engl. J. Med., August 25, 2005; 353(8): 824 - 832. [Full Text] [PDF]
|
|
|
|
 |
|
 E. S. Prakash and Madanmohan When the heart is stopped for good: hypotension-bradycardia paradox revisited Advan Physiol Educ, March 1, 2005; 29(1): 15 - 20. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. K. Shen, W. W. Decker, P. A. Smars, D. G. Goyal, A. E. Walker, D. O. Hodge, J. M. Trusty, K. M. Brekke, A. Jahangir, P. A. Brady, et al. Syncope Evaluation in the Emergency Department Study (SEEDS): A Multidisciplinary Approach to Syncope Management Circulation, December 14, 2004; 110(24): 3636 - 3645. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Kumar Sinha, S. Manikandan, T. I. Usichenko, and D. Pavlovic Reducing Venipuncture Pain by Cough Trick * Response Anesth. Analg., September 1, 2004; 99(3): 952 - 953. [Full Text] [PDF]
|
|
|
|
 |
|
 J. J. Van Lieshout, W. Wieling, J. M. Karemaker, and N. H. Secher Syncope, cerebral perfusion, and oxygenation J Appl Physiol, March 1, 2003; 94(3): 833 - 848. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C.T. P. Krediet, N. van Dijk, M. Linzer, J. J. van Lieshout, and W. Wieling Management of Vasovagal Syncope: Controlling or Aborting Faints by Leg Crossing and Muscle Tensing Circulation, September 24, 2002; 106(13): 1684 - 1689. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. S. Takata, S. L. Wasmund, M. L. Smith, J.-M. Li, J. A. Joglar, K. Banks, R. C. Kowal, R. L. Page, and M. H. Hamdan Serotonin Reuptake Inhibitor (Paxil) Does Not Prevent the Vasovagal Reaction Associated With Carotid Sinus Massage and/or Lower Body Negative Pressure in Healthy Volunteers Circulation, September 17, 2002; 106(12): 1500 - 1504. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Ammirati, F. Colivicchi, and M. Santini Permanent Cardiac Pacing Versus Medical Treatment for the Prevention of Recurrent Vasovagal Syncope : A Multicenter, Randomized, Controlled Trial Circulation, July 3, 2001; 104(1): 52 - 57. [Abstract] [Full Text] [PDF]
|
|
Article
